PMGC Holdings Inc
Research PMGC Holdings Inc (ELAB) on Bullrun: market cap USD 25.85M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerELAB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 25.85M
- Financial periodQ1 2026
- RevenueUSD 1.27M
- Net income-USD 11.11M
- Free cash flow-USD 3.34M
- Gross margin32.7%
Valuation Snapshot
latest market cap is USD 25.85M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 590.08K | -USD 7.75M | -USD 6.38M | 31.4% | -784.83 | USD 5.40M | USD 2.64M | USD 7.84M |
| FY2024 | -USD 1.75M | -USD 6.25M | -USD 5.50M | n/a | -1897.51 | USD 3.98M | USD 0 | USD 6.66M |
| FY2023 | USD 1.71M | -USD 4.30M | -USD 4.57M | 66.2% | -0.4 | USD 3.33M | USD 210.49K | USD 3.83M |
| FY2022 | USD 766.28K | -USD 1.80M | n/a | 58.4% | -0.19 | USD 1.15M | n/a | USD 1.13M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 25.85M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.87M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 7.02M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 21.55M | n/a | n/a | n/a |
About PMGC Holdings Inc
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PMGC Holdings Inc's market cap?
PMGC Holdings Inc's market capitalization is USD 25.85M.
What does PMGC Holdings Inc do?
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.